DNDi has had a significant presence in Asia for the past 20 years, with physical offices established in Malaysia (Kuala Lumpur), India (Delhi), and Japan (Tokyo). Beyond these locations, DNDi has implemented projects and formed partnerships in several other countries, including Bangladesh, Nepal, Sri Lanka, Thailand, Korea, Indonesia, and Singapore. The breadth of these partnerships ranges across diverse sectors, such as collaborations with various ministries, research and academic institutions, pharmaceutical companies, contract manufacturers, and political engagements with global forums like G7 and G20 etc. In Asia DNDi also works closely with large donors and international organizations to support its mission. Our collaborations in Asia span the full spectrum of drug discovery and development, from initial research to Phase I through Phase III clinical trials, ensuring that essential drugs are accessible to those who need them. The key diseases of focus in the region include hepatitis C, dengue, leishmaniasis, lymphatic filariasis, and mycetoma. Additionally, we are exploring new opportunities to collaborate on drug discovery consortia and development of drugs for other diseases to address unmet medical needs in the region.
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development (R&D) organization that develops and delivers new treatments for neglected diseases affecting millions of the world’s poorest people.
Together with more than 200 public research and industry allies worldwide, we use the power of partnership, innovation, open science, and advocacy to find solutions to a great injustice: the lack of medicines for life-threatening diseases that disproportionately impact poor and marginalized people. Driven by collaboration, not competition, and by patients’ needs, not profits, we promote equitable access, foster inclusive and sustainable solutions, and advocate for a more effective global biomedical R&D system that meets the needs of neglected patients.
Since our inception, DNDi has delivered 13 new treatments for people with sleeping sickness, visceral leishmaniasis, Chagas disease, HIV, hepatitis C, and malaria that have saved millions of lives. We aim to deliver a total of 25 new treatments by 2028– addressing R&D gaps for neglected tropical diseases and viral infections, including new pandemic-prone diseases (such as COVID-19) and climate-sensitive diseases (such as dengue) with a focus on the needs of patients in low- and middle-income countries.
With more than 200 employees of 25+ nationalities located in eight offices on four continents, DNDi is committed to diversity, equity, and inclusion as essential parts of our culture and key drivers of our success. We encourage candidates of diverse profiles and backgrounds to apply.
The Director, South Asia Regional Office occupies a senior position for DNDi and has as main responsibilities to actively lead the institutional development in the India sub-continent for DNDi, to engage with senior stakeholders for DNDI and to manage the DNDI South Asia Regional Officer. The Director is part of DNDi’s global leadership team.
The overall purpose of this position is:
Regional Director Responsibilities (South Asia: India, Bangladesh, Nepal and Sri Lanka)
Reporting line
Interactions
DNDi is committed to building a diverse, equitable and truly inclusive organisation. Our success and global reach are dependent upon our ability to encourage diversity and draw on the skills, understanding and experience of all our people. We particularly welcome applications from those who are underrepresented in at DNDi and across the sector, especially women, and including, but not limited to, black and minority ethnic candidates, and those with other protected characteristic.